HDAC3 and gastric cancer: Overall, this study demonstrates that HDAC3 may be a positive regulator of EMT and tumor metastasis in gastric cancer through transcriptional repression of E-cadherin via C/EBPβ and NFκB-p65 gene regulation, which can be significantly inhibited by treatment with Honokiol or HDAC3 inhibitors.